Reduced drug uptake in phenotypically resistant nutrient-starved nonreplicating Mycobacterium tuberculosis

by Sarathy, J., Dartois, V., Dick, T., Gengenbacher, M.
Published 2014

Polyamines Inhibit Porin-Mediated Fluoroquinolone Uptake in Mycobacteria

by Sarathy J.P., Lee E., Dartois V.
Published 2018

Teicoplanin - Tigecycline combination shows synergy against Mycobacterium abscessus

by Aziz, D.B, Teo, J.W.P, Dartois, V, Dick, T
Published 2020

Rifabutin Is active against mycobacterium abscessus complex

by Aziz, D.B, Low, J.L, Wu, M.-L, Gengenbacher, M, Teo, J.W.P, Dartois, V, Dick, T
Published 2020

Gut microbiota metabolite indole propionic acid targets tryptophan biosynthesis in Mycobacterium tuberculosis

by Negatu, D.A., Yamada, Y., Xi, Y., Go, M.L., Zimmerman, M., Ganapathy, U., Dartois, V., Gengenbacher, M., Dick, T.
Published 2022

BCG induces protection against Mycobacterium tuberculosis infection in the wistar rat model

by Singhal A., Mathys V., Kiass M., Creusy C., Delaire B., Aliouat E.M., Dartois V., Kaplan G., Bifani P.
Published 2019

Whole-cell screen of fragment library identifies gut microbiota metabolite indole propionic acid as antitubercular

by Negatu, D.A, Liu, J.J.J, Zimmerman, M, Kaya, F, Dartois, V, Aldrich, C.C, Gengenbacher, M, Dicka, T
Published 2020

Pyrazinamide resistance is caused by two distinct mechanisms: Prevention of coenzyme a depletion and loss of virulence factor synthesis

by Gopal, P, Yee, M, Sarathy, J, Liang Low, J, Sarathy, J.P, Kaya, F, Dartois, V, Gengenbacher, M, Dick, T
Published 2020

Pharmacokinetic-pharmacodynamic analysis of spiroindolone analogs and KAE609 in a murine malaria model

by Lakshminarayana S.B., Freymond C., Fischli C., Yu J., Weber S., Goh A., Yeung B.K.S., Ho, Chi Lui Paul, Dartois V., Diagana T.T., Rottmann M., Blasco F.
Published 2016

Comprehensive analysis of methods used for the evaluation of compounds against Mycobacterium tuberculosis

by Franzblau, S.G., Degroote, M.A., Cho, S.H., Andries, K., Nuermberger, E., Orme, I.M., Mdluli, K., Angulo-Barturen, I., Dick, T., Dartois, V., Lenaerts, A.J.
Published 2014

NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans

by Gengenbacher, M, Duque-Correa, M.A, Kaiser, P, Schuerer, S, Lazar, D, Zedler, U, Reece, S.T, Nayyar, A, Cole, S.T, Makarov, V, Barry, C.E, Dartois, V, Kaufmann, S.H.E
Published 2020

Impact of immunopathology on the antituberculous activity of pyrazinamide

by Blanc, L, Sarathy, J.P, Cabrera, N.A, O’Brien, P, Dias Freedman, I, Mina, M, Sacchettini, J, Savic, R.M, Gengenbacher, M, Podell, B.K, Prideaux, B, Ioerger, T, Dick, T, Dartois, V
Published 2020

Experimental tuberculosis in the wistar rat: A model for protective immunity and control of infection

by Singhal A., Aliouat E.M., Hervé M., Mathys V., Kiass M., Creusy C., Delaire B., Tsenova L., Fleurisse L., Bertout J., Camacho L., Foo D., Tay H.C., Siew J.Y., Boukhouchi W., Romano M., Mathema B., Dartois V., Kaplan G., Bifani P.
Published 2019

Mycolic acids as diagnostic markers for tuberculosis case detection in humans and drug efficacy in mice

by Shui, G., Bendt, A.K., Jappar, I.A., Lim, H.M., Laneelle, M., Hervé, M., Via, L.E., Chua, G.H., Bratschi, M.W., Rahim, S.Z.Z., Michelle, A.L.T., Hwang, S.-H., Lee, J.-S., Eum, S.-Y., Kwak, H.-K., Daffé, M., Dartois, V., Michel, G., Barry, C.E., Wenk, M.R.
Published 2014

Indolcarboxamide is a preclinical candidate for treating multidrug-resistant tuberculosis

by Rao, S.P.S., Lakshminarayana, S.B., Kondreddi, R.R., Herve, M., Camacho, L.R., Bifani, P., Kalapala, S.K., Jiricek, J., Ma, N.L., Tan, B.H., Ng, S.H., Nanjundappa, M., Ravindran, S., Seah, P.G., Thayalan, P., Lim, S.H., Lee, B.H., Goh, A., Barnes, W.S., Chen, Z., Gagaring, K., Chatterjee, A.K., Pethe, K., Kuhen, K., Walker, J., Feng, G., Babu, S., Zhang, L., Blasco, F., Beer, D., Weaver, M., Dartois, V., Glynne, R., Dick, T., Smith, P.W., Diagana, T.T., Manjunatha, U.H.
Published 2016